Enovis Corp. (ENOV)
21.82
-1.55
(-6.63%)
USD |
NYSE |
Mar 27, 16:00
21.82
0.00 (0.00%)
Pre-Market: 20:00
Enovis EPS Diluted (Quarterly) : -9.074 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -0.0219 |
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1428 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -518.80M |
| Revenue (Quarterly) | 575.76M |
| Total Expenses (Quarterly) | 1.095B |
| Enterprise Value | 2.594B |
| Gross Profit Margin (Quarterly) | 51.58% |
| Profit Margin (Quarterly) | -90.11% |
| Earnings Yield | -94.83% |
| Operating Earnings Yield | 0.09% |
| Normalized Earnings Yield | -31.39 |